In IDH1 mutated AML cells, ATRA effects were significantly reduced by the inhibition of 2-HG production, whereas in wild-type IDH1 cells, the treatment with a cell-permeable form of 2-HG sensitized cells to ATRA-induced myeloid differentiation [68]. This evidence concerns the gene IDH1 and acute myeloid leukemia.